Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD
237.60
+24.60 (11.55%)
At close: Apr 24, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 582.36M | - | - | - |
| - | 466.68M | 316.63M | 212.47M |
| - | 47.39% | 49.03% | - |
| 582.36M | 466.68M | 316.63M | 212.47M |
| 24.79% | 47.39% | 49.03% | - |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
|---|
| 466.68M | 316.63M | 212.47M |
| 47.39% | 49.03% | - |
| 466.68M | 316.63M | 212.47M |
| 47.39% | 49.03% | - |
Source: S&P Global Market Intelligence.